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Summary Quantification of metabolite ordrug concentrations in living tissues requires determination of intra- and extracellular volumes. This
study demonstrates how this can be achieved non-invasively by 31p magnetic resonance spectroscopy (MRS) employing dimethyl
methylphosphonate (DMMP) as a marker of total water space, 3-aminopropylphosphonate (3-APP) as a marker of extracellular space and P,
and 3-APP as markers of intracellular pH (pH,) and extracellular pH (pH) respectively. The MRS measurements of the tumour volumes were
validated by classic radiolabelling methods using 3H20 and ['4C]inulin as markers of total and extracellular space respectively. The
extracellular volume fraction measured by radiolabelling of RIF-1 tumours was 23 ± 0.83% (mean ± s.e.m. n = 9), not significantly different
(P > 0.1) from that found by MRS (27 ± 2.9%, n = 9, London, and 35 + 6.7, n = 14, Baltimore). In untreated RIF-1 tumours, pHl was about
0.2 units higher than PHe (P < 0.01). 5-Fluorouracil (5FU) treatment (165 mg kg') caused no significant changes in either PHe or per cent
extracellular volume. However significant increases inpH1 48 h aftertreatment (P< 0.01) correlated with decreased tumour size and improved
bioenergetic status [NTPfinorganic phosphate (P.) ratio]. This study shows the feasibility of an MR method (verified by a gold standard') for
studying the effects of drug treatment on intra- and extracellular spaces and pH in solid tumours in vivo.
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Determination ofaccurate metabolite concentrations is essential to
elucidate tumour biochemistry and its relationship to underlying
tissue physiology. Understanding the mechanisms that cause
biochemical and physiological changes in tumours. particularly
in response to treatment (Braunschweiger and Schiffer. 1986:
Braunschwveigyer. 1988). is crucial in the quest to cure cancer.
Current magnetic resonance spectroscopy (MRS) techniques for
quantification reference the metabolite level to an external refer-
ence signal or an internal reference such as water (Thulborn and
Ackerman. 1983: Shungu et al. 1992a). Changes in signal intensity
detected following a therapeutic orphysiological intervention (e.a.
administration of a cancer drug or modification of tumour blood
flow respectively) may be due either to a change in the amount of
specific metabolites or to achange in the intracellular volume frac-
tion. A method for measuring non-invasively the intra- and extra-
cellular volume fraction is necessary to distinguish between these
possibilities. Here we demonstrate that this can be accomplished
by 5IP-MRS using dimethyl methylphosphonate (DMMP) and 3-
aminopropylphosphonate (3-APP) as markers for total and extra-
cellular water spaces respectively. DMMP is distributed among all
the water spaces. whereas 3-APP accesses only the extracellular
compartment: both compounds are chemically inert and non-toxic
and are. therefore. suitable as compartmental volume indicators
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(Barn et al. 1993; Clarke et al. 1994: Gillies et al. 1994). Here we
have validated this method blr comparison with classical radio-
labelling methods (HO and ['4C]inulin).
In a 'H-MRS study of RIF-1 tumours responding to 5-fluo-
rouracil (5FU) therapy. a decrease in trimethylamine and lactate
signals was detected (Shungu et al. 1992b). However. Whether
these decreases resulted from a decrease in the intracellular quan-
tities of these metabolites or from a chance in the intracellular
volume fraction is not known. and information on volume fraction
would allow us to distinguish between these two possibilities. In
addition. distinction between intra- and extracellular compart-
ments is particularly important in pH measurements ofnormal and
tumour tissue. The hydrogen ion (H+) concentration of the intra-
and extracellular milieu can influence drug uptake or repair of
cellular damage (Hult and Larson. 1976: Hofer and Mivechi.
1980: Nissen and Tanneberger. 1981). As 3-APP also serves as an
indicator of extracellular pH (pH) (Gillies et al. 1994) and inor-
ganic phosphate (P) is predominantly in the intracellular compart-
ment and is. hence. an endogenous indicator of intracellular pH
(pH) under most conditions (Stubbs et al. 1992). we have also
monitored changes in pH and pHe of RIF-1 tumours following
treatment with 5FIT. Several agents such as 5FUT or radiation are
known to induce changes in pH following treatment (Tozer et al.
1989: Li et al. 1991). However. the contribution of the intra- and
extracellular compartments to these chances has not been
adequately defined.
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Table 1 T1 values obtained for the injection solution and for tumours in vivo
Sample T1 3-APP (s) T. DMMP (s)
Injection solution (n = 2) 1.7 ± 0.3 14.3 ± 0.2
Tumours in vivo (n = 3) 6.1 +0.2 13.7 ± 0.8
Error bars represent s.e.m.
METHODS
The studies were carried out at two different sites: London (St.
George's Hospital Medical School) and Baltimore (The Johns
Hopkins University School of Medicine). Whereas the fractional
volume measurements were made by both the MRS and radio-
labelling method in London using separate cohorts of tumours.
fractional volume measurements were made by the MRS method
only in Baltimore. The pH measurements were made from the
MR spectra at both sites, but response to tumour treatment was
monitored in Baltimore only.
Animals and tumours
Studies at both sites were performed on RIF-1 tumours grown
subcutaneously in the flanks of C3H/HeN mice in either London
or Baltimore. The mice in London were fed on Special Diet
Services. Rat and Mouse maintenance No. 1 (Lillico. Betchworth.
Surrey). whereas in Baltimore mice were fed on Teklad LM-485
Mouse/Rat sterilizable diet (Harlan. Teklad. Madison. WI. USA).
Tumours were grown according to the protocol of Twentyman
et al (1980). Tumours were between 300 and 1000 mm3 when
used. Mice were anaesthetized with a combination of ketamine
(50 mg kg-': Aveco) and acepromazine (5 mg kg-': Aveco) in
Baltimore or ketamine (50 mg kg-': Parke-Davis. UK) and
diazepam (25 mg kg-'; Phoenix Pharmaceuticals. UK) in London.
They were subsequently injected intraperitoneally with a solution
of 3-APP (480 mg kg-': Sigma) and DMMP (480 jl kg-': Sigma)
administered in a volume of0.2 ml ofsaline.
MRS studies
MRS studies were performed on either a GE (Baltimore) or SISCO
(London) 4.7-T horizontal magnet. using home-built solenoidal
coils (10.5 mm in diameter). which were placed over the tumours
with the mice in the supine position. A proton image through the
centre ofatumourusing the same coil as that used to acquire the 3'P
spectra demonstrated that there was negligible contribution from
tissue outside ofthe tumour. The mice were placed on aflask orpad
containing recirculating warm water to maintain a constant body
temperature around 370C. The same coils were used to obtain
spectra of the injection solution (DMMP and 3-APP). As it is
known that the T, values of phosphonates are longer in solution
than in tissue (Clarke et al. 1994). the T, values ofboth 3-APP and
DMMP were measured by an inversion recovery sequence in solu-
tion and in vivo (Table 1). The spectra of the solution of DMMP
and 3-APP (an equal amount of each) were acquired with a single
scan. firstly with a45° pulse and subsequently with a900 pulse; the
time interval between the two spectra was 1 min.
In vivo spectra were acquired with the following parameters:
450 flip angle. recycle time (tr) = 10 or 20 s. number ofaquisitions
(na) = 64 followed by two partially saturated spectra (tr = 1 s.
Table 2 Saturation factors calculated for the repetition times used
Factor f Factor f
Repetfition time(s) where (M = fMo) where ( = fMo)
for 3-APP for DUMP
10 0.933 0.786
20 0.987 0.917
30 0.998 0.964
For details and equation see text.
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Figure 1 31P MR-spectra of RIF-1 tumours taken in A Batimore and
B London. Peak assignments as follows: (1) 3-APP, (2) DMMP,
(3) osphomonoesters, (4) P. (5) phosphodiesters, (6) PCr, (7) y-NTP,
(8) a-NTP, (9) P-NTP. For oher details see Methods
na = 200 Baltimore only). with a further fully relaxed spectrum
(parameters as before). The partially saturated spectra were
obtained to confirm the chemical shift positions with improved
signal to noise for the pH measurements before and after 5FU
treatment. Analysis of the 3-APP and DMMP resonances at both
centres was obtained from the mean of two fully relaxed scans
(total na = 128). In addition. analysis of 3-APP and DMMP reso-
nances before and after a time interval of6-7 min ensured that the
two compounds were at equilibrium over the time ofobservation.
A spectrum of the injection solution was obtained before each
animal experiment to take into account any evaporation of the
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Figure 2 A 31P-MR spectrum obtained from a representative RIF-1 tumour
A before and B 48 h after 165mg kg-' 5-FU. Foracqisition parameters see
Methods. Tumour volume was 249 nn3 on day 0 and regessed to 148 mrn
by 48 h
solution. These spectra were used to calculate the fractional.
volumes (see below for details). Additional experiments were
performed to ascertain that the rate of clearance of both
compounds was similar and that they cleared within 24 h of
administration, and this was, indeed, the case.
Data analysis and quantitation
Fully relaxed spectra were usedforthequantitative estimation ofthe
fractional volumes, and in-house computer methods were used for
quantifying the peaks at both sites. In Baltimore, data sets were
processed using an exponential line-broadening factor of 22 Hz.
Peak areas were determined in the time domain using an in-house
non-linear least squares curve-fitting routine for MR data analysis
written by Dr DC Shungu. In London, after 20 Hz line broadening,
the MR spectra were analysed using VARPRO, a time domain
fitting routine (van derVeen et al, 1988). The DMMPpeak area was
assumed to be proportional to the amount ofDMMP in the sensitive
volume of the coil, and equivalent to the total water volume of the
tumour(in the sensitive volumeofthecoil). Analogously, the 3-APP
peak resonance area was assumed to be proportional to the amount
of 3-APP in the tumour. DMMP and 3-APP resonances in the
in vitro spectra were analysed in a similar way.
Using equation 1, the T, values measured and a flip angle
a = 450, saturation factors were derived for the repetition times
used in the study (Table 2) and were taken into account in the data
analysis.
M_ Wt = Mo ( -exp-tf )/(I-cosaexpt'r-)(1)
The intra- and extracellular volumes from the MRS data were
calculated from the mean of two fully relaxed in vivo spectra and
the spectrum ofthe injection solution (so[) as follows:
% extracellular space =
Mo(3-APP)/Mo(DMMP), X1,0xMo(DMMP)/Mo(3-APP)dxlOO
pH,and pH,measureents
pHi was calculated from the chemical shift difference between
inorganic phosphate (P) and a-NTP (an endogenous reference at
-7.57 p.p.m. relative to phosphocreatine at 0 p.p.m.), and pHe was
calculated from the chemical shift difference between the 3-APP
resonance and a-NTP. The chemical shifts were taken from the
maximum resonance of the relevant species. pHi was calculated
from the relationship pH = 6.66 + log[6Pi - 0.651/(3.11 - 6Pi).
where 6 denotes the chemical shift in p.p.m. PHe was calculated
from the relationship pH = 6.91 - log[8 3-APP - 21.1111
(24.3 -6 3-APP) (Gillies et al. 1994, see also McCoy et al. 1995).
Results are expressed as mean ± 1 s.e.m.
Radioabelling studies
Extracellular volume was assessed by measuring the distribution
of 3HO (as a marker of total cell water) and [14C]inulin (as a
marker ofextracellular space). Tumours were freeze clamped with
liquid nitrogen-cooled tongs 20 min after tail-vein injection of
40 gCi of3ROand 1 gCi of[14C]inulin (obtained from Amrersham
International, Amersham. Bucks. UK). The whole tumour was
extracted with 6% perchloric acid and neutralized as described in
Bergmeyer (1974). Blood plasma was obtained by centrifugation
ofa whole blood sample taken from the mouse atthe time offreeze
clamping. The plasma supernatant was deproteinized with 6%
perchloric acid. The tumour and plasma samples were subse-
quently neutralized and counted for radioactivity. Tine course
measurements showed that equilibration ofthe label with the body
fluids occurred within 20 min. Total water content was measured
by comparing 3HO counts in the tissue with those of the plasma
(i.e. 3HO c.p.m. per g wet wtPH,O c.p.m. per ml plasma =
ml H,O/g wet wt). Similarly, extracellular volumes were calcu-
lated by making comparisons ofthe '4C inulin distribution between
tissue and plasma samples taken at the same time and the results
were expressed as a percentage of total cell water (i.e. ml extra-
cellular water/ml total cell water x 100). Extracellular volumes
were also measured in a control tissue (liver n = 7).
5FU studies
Of the 15 animals studied in Baltimore. eight were treated with
165 mg kg-' 5-FU, with seven acting as controls. Animals were
studied by 31P-MRS at 0 and 48 h. None of the animals exhibited
any overt signs of toxicity such as loss of weight or appetite;
tumour growth in the untreated animals was not affected-
RESULTS
MRS vs radiolabelling measurements of extracellular
space
Representative spectra ofRIF-I tumours from both Baltimore and
London obtained using similar acquisition parameters are shown
in Figure 1. Resonances from endogenous a-. >- and y-NTP Pi and
a small contribution from PCr are seen, as are resonances from
DMMP and 3-APP, administered by i.p. injection. Calculation of
the extracellular water content (see Methods) was made from the
3'P-MR spectra ofRIF-1 tumours (both in Baltimore and London)
and from the radiolabelling results (London only). At 23.0 ± 0.83
(mean ± 1 s.e.m.) vs 27± 2.9% (n = 9) for the radiolabelling and
MRS respectively (London). there was no significant difference
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Figure 3 A 31P-MR spectrum obtained from a RIF-1 tumour A before and B
48 h after 165 mg kg-' of 5-FU, which showed a Large increase in both
NTP/P ratio and in pH, and PHe after treatment For acquistion parameters
see Methods. Tumour volume was 500 mm3 on dayO and regressed to
300 mm3 by 48 h
between the two techniques (P > 0.1). This compared well with
35 ±6.7 (n = 14) forthe MRS method found in Baltimore (P >0.1)
compared with either 'gold standard' or London MRS values.
From the radiolabelling studies we were able to calculate that the
total water content of the tumours was 0.91 ± 0.08 ml g-' wet wt
compared with 0.74 +0.04 (n = 8) in liver. The extracellular space
of the tumours was significantly higher than that of livers
(16.6 + 0.76%, n = 7 (P < 0.0001) and similar to that found previ-
ously in rat tumours (Stubbs et al. 1992).
pH, and pHe of RIF-1 tumours
pH values for the untreated set of tumours measured in London
gave values forpHi of 7.06 ± 0.03 (n = 9). and pHe of6.81 ± 0.07
(n = 9). confirming the relatively more acidic extracellular pH
found previously (Gillies et al. 1994: McCoy et al. 1995). Both pH
and PHe values for the Baltimore tumours were slightly higher:
pH- 7.20 ± 0.04 and pH 7.02 ± 0.11 (n = 14).
Effect of 5-FU on pH and extracellular volume
1P-MR spectra (Baltimore) obtained from a RIF-l tumour before
and 48 h after 5-FU and representative of most of the tumours
studied are shown in Figure 2A and B respectively. The tumour
volume had regressed from 249 mm3 to 148 mm3 during this time.
The NTP/P- ratio and the pH. had both increased and a statistical
summary of the data are presented in Figure 4. Although pHi of
RIF-1 tumours is usually 7.1-7.2. one tumour demonstrated a
dramatic change in both intra- and extracellular pH, which can
occur following 5-FU (Figure 3A and B). In this tumour pH.
increased from 6.8 to 7.44. and pHe increased from 6.8 to 7.24
48 h after 5FU treatment. The overall changes in tumour volume.
pH andNTP/P-, forcontrol and treated tumours are shown in Fig 4
A-C. As observed previously. pH- decreased significantly in the
control tumours as the tumour volume increased. However, a
significant increase inpH, (paired l-test. P<0.019. n = 8) was seen
following treatment with 5-FU, from 7.15 ± 0.07 to 7.38 ± 0.04
within 48 h. PHe increased by more than 0.6 units in one tumour
(Figure 3), which had both PH. and pHi below 6.8. Overall.
however, there was no significant change in pHe following 5-FU.
Treatment with 5-FU also resulted in a small but significant
increase inNTP/P, by 48 h (P < 0.05).
As mentioned previously. the extracellular volume fraction
within RIF-1 tumours before treatment was found to be similar
(35 ± 6.7%) to those measured in London (27 ± 2.9%). When
tumours were separated into treated and untreated groups. the
extracellular volume fraction was 33 ± 5.3% at time 0. and 35 ±
5.6% at 48 h after treatment. The volume fraction for the untreated
tumours was 38± 8% and 39.0± 4.2% for0 and 48 h respectively.
DISCUSSION
Clarke et al (1994) have validated 'P-MRS measurements of
extracellular space in isolated rat hearts using phosphonates as
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Figure 4 Changes in A tumour volume, B pH, and C NTP/PI at 0 and 48 h for (a) control tumours (n = 7) and (0) tumours treated with 165 mg kg-' 5-FU
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markers of different water spaces [DMMP for total water space
and phenylphosphonic acid (PPA) as a marker of extracellular
space]. Here we have shown that data obtained with the markers
DMMP and 3-APP. which we have already shown is a useful
marker of pH, (Gillies et al. 1994). are in good agreement with
values obtained using classical invasive methods for measuring
volume fractions in an experimental tumour model. We also found
that the extracellular volume fraction did not change significantly
following 5FU treatment.
In contrast to the findings with SIJ in the present study.
Braunschweiaer (1988). using cyclophosphamide treatment and
classical radiolabel methods that involved excising the tumours.
demonstrated increases in RIF-1 tumour plasma and interstitial
water volumes within 48 h of treatment. However. the modes of
action of these two drugs are quite different. and therefore the
observed differences in response are not totally unexpected.
Changes in tissue water compartmentation after treatment involve
complex physiological phenomena such as transient ischaemia.
intermittent perfusion and vascular collapse. which occur in solid
tumours. and these mav contribute to the differences observed.
An additional interesting feature of cyclophosphamide treat-
ment is that it causes an increase in the apparent diffusion coeffi-
cient (ADC) of water measured by diffusion weinhted
spectroscopy (Zhao et al. 1996). which is consistent with an
increase in the fractional water content. However, the changes in
ADC are difficult to interpret and the MRS method of measuring
water spaces described in this paper may prove useful in conjunc-
tion with diffusion weighted spectroscopy measurements to aid in
the interpretation oftreatment-induced changes in the intensities of
metabolite signals and as a potential predictor ofresponse. Indeed
other non-invasive MR methods such as multiexponential T,
measurements may provide information on extracellular volume
fractions at much higher spatial resolution (Whittall et al. 1997) in
vivo. Determininn whether the information obtained bv such tech-
niques does actually represent extracellular volume fractions is
crucial to their potential usefulness. and comparisons made with
the method described in this paper could be important.
A significant increase in pH at 4 h following a dose of
165 ma kg-' 5LTFU was observed consistently. As mentioned
earlier. significant changes in pH have been observed following
different forms oftreatment such as radiation and chemotherapy in
several other studies (Tozer et al. 1989: Li et al. 1991). These
changes are usually attributed to an improvement in perfusion and
bioenergetic status within the tumour (Tozer et al. 1989) followinur
treatment. However. for such an effect to occur. one has to assume
that pH regulation is enerux limited in these tumours. Indeed. there
is some evidence for this. both from Ehrlich ascites cells. in which
pH homeostasis has been shown to be ATP dependent (Gillies et
al. 1982). and from the study of Bhujwalla et al (1991). in which
supplying glucose directly to RIF-1 tumours resulted in a silnifi-
cant increase in pH, and NTP/P. This is also consistent with our
observation that treated tumours showed a small but significant
increase in NTP/P following 5FWI. RIF-I tumours have necrotic
fractions ofthe order of5-10%c (Tozer et al. 1989).
The reasons for the differences in the absolute values of pH are
not readily explained as measurements were made on machines of
similar field strength. on the same turnour type and using the same
standard curves for calculating pH. These differences have been
apparent throughout our many years of collaboration and must be
put down to some basic biological differences that have developed
in the tumours over years of passage and/or to the differences in
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animal chow used in the USA and UK (e.g. 19%7c crude protein
used in the US diet compared with 14.7%2 used in the UK diet).
However. the absolute values are not so important and do not
effect the experimental conclusions. as each animal serves as its
own control.
With the exception of one tumour the results suggest that. as
long as the initial pH was higher than 7.0. and pH higher than 6.8.
the treatment-induced changes in pH Awere not accompanied by an
increase inpH.' All treated tumours decreased in size by more than
40%7 following treatment. but studies relating cell survival to
changes in pH (intra- and extracellular) remain to be performed. It
is possible that the increase in pH observed following 5FU may be
related to attempts by the tumour cells to export the cytotoxic drug,
(Simon et al. 1994). An increase in pH, in RLF-1 tumours 2 h after
treatment with 5FU has also been observed (NMcSheehy- et al.
1998). In conclusion. this study demonstrates the feasibility and
the importance of tracking changes non-invasively in the content
and quantity oftumour milieu following treatment.
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